Evidence Based Medicine Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
EXAI | F | Exscientia Limited | -5.78 | |
GTH | B | Genetron Holdings Limited | 0.00 | |
WGS | B | GeneDx Holdings Corp. | -3.45 |
Related Industries: Biotechnology Diagnostics & Research Health Information Services
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBB | C | iShares Nasdaq Biotechnology Index Fund | 0.05 | |
ITOT | B | iShares Core S&P Total U.S. Stock Market ETF | 0.0 |
Compare ETFs
Date | Stock | Title |
---|---|---|
May 21 | EXAI | Exscientia to lay off up to 25% of employees; shares down 10% |
May 21 | EXAI | Exscientia GAAP EPS of -$0.21, revenue of $6.7M |
May 21 | EXAI | Exscientia Business Update for First Quarter 2024 |
May 20 | EXAI | Exscientia Q1 2024 Earnings Preview |
- Evidence Based Medicine
Evidence-based medicine (EBM) is "the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients." The aim of EBM is to integrate the experience of the clinician, the values of the patient, and the best available scientific information to guide decision-making about clinical management. The term was originally used to describe an approach to teaching the practice of medicine and improving decisions by individual physicians about individual patients.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles